Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bisphosphonates and osteoporosis.

Literature DB >> 8461567

Bisphosphonates and osteoporosis.

O H Sørensen¹, T Storm, G Thamsborg, H A Sørensen, G Kollerup, T Steiniche, F Melsen, H K Genant.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Diphosphonates

Year: 1993 PMID： 8461567 DOI： 10.1007/bf01621913

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

× No keyword cloud information.

17 in total

1. The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime.

Authors: T Steiniche; C Hasling; P Charles; E F Eriksen; F Melsen; L Mosekilde
Journal: Bone Date: 1991 Impact factor: 4.398

2. Prevention of postmenopausal bone loss by tiludronate.

Authors: J Y Reginster; M P Lecart; R Deroisy; N Sarlet; D Denis; D Ethgen; J Collette; P Franchimont
Journal: Lancet Date: 1989 Dec 23-30 Impact factor: 79.321

3. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.

Authors: R Pacifici; C McMurtry; I Vered; R Rupich; L V Avioli
Journal: J Clin Endocrinol Metab Date: 1988-04 Impact factor: 5.958

4. Preliminary observations of a form of coherence therapy for osteoporosis.

Authors: C Anderson; R D Cape; R G Crilly; A B Hodsman; B M Wolfe
Journal: Calcif Tissue Int Date: 1984-05 Impact factor: 4.333

5. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

Authors: P M Boonekamp; L J van der Wee-Pals; M M van Wijk-van Lennep; C W Thesing; O L Bijvoet
Journal: Bone Miner Date: 1986-02

6. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.

Authors: R D Hesch; J Heck; G Delling; E Keck; J Reeve; H Canzler; O Schober; H Harms; E F Rittinghaus
Journal: Klin Wochenschr Date: 1988-10-03

7. Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study.

Authors: A B Hodsman
Journal: Bone Miner Date: 1989-01

Bisphosphonates and osteoporosis.

1. The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime.

2. Prevention of postmenopausal bone loss by tiludronate.

3. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.

4. Preliminary observations of a form of coherence therapy for osteoporosis.

5. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

6. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.

7. Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study.

8. Effect of etidronate disodium on bone turnover following surgical menopause.

9. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

10. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

1. Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling.

2. Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosis.